Related Experiment Video
Updated: Jun 12, 2025

Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations
Published on: July 21, 2023
Scoping Review: Is Push-Dose Norepinephrine a Better Choice?
Michael Berkenbush1, Lali Singh1, Kelly Sessa1
1Morristown Medical Center, Sameth Emergency Department, Morristown, New Jersey.
Push-dose norepinephrine is safe and effective for treating hypotension, particularly in anesthesia. This review highlights its benefits over other vasopressors, suggesting further research in critical care settings.
Area of Science:
- Anesthesiology
- Critical Care Medicine
- Pharmacology
Background:
- Push-dose vasopressors are commonly used to manage anesthesia-induced hypotension.
- Norepinephrine is increasingly considered as an alternative to phenylephrine and epinephrine.
- Evidence for push-dose norepinephrine in emergency and critical care is limited.
Purpose of the Study:
- To evaluate the clinical use and evidence surrounding push-dose norepinephrine.
- To compare the efficacy and safety of push-dose norepinephrine with other vasopressors.
- To identify research gaps in the emergency and critical care settings.
Main Methods:
- A scoping review of publications on push-dose norepinephrine in human subjects.
- Searched PubMed and Google Scholar for relevant research studies.
- Included randomized controlled trials comparing norepinephrine to phenylephrine, ephedrine, and epinephrine.
Main Results:
- A majority of studies focused on spinal anesthesia for cesarean sections; fewer addressed general anesthesia.
- Limited literature exists for emergency and critical care applications.
- Norepinephrine was demonstrated to be safe and effective in 27 reviewed studies, including 17 randomized controlled trials.
Conclusions:
- Push-dose norepinephrine shows safety and efficacy, with favorable hemodynamic markers compared to other agents.
- Clinical benefits include ease of administration and reduced need for repeat doses.
- Further high-quality research in emergency and critical care is recommended to confirm findings.
Related Concept Videos
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Adrenergic Agonists: Direct-Acting Agents
These agents can be classified...
Drug Delivery: Enteral Route
Adrenergic Agonists: Mixed-Action Agents
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
Drugs Affecting Neurotransmitter Release or Uptake

